HomeNewsBusinessWill reverse migration of techies pave way for IT sector's growth in smaller cities?

Will reverse migration of techies pave way for IT sector's growth in smaller cities?

Analysts and human resource professionals pointed out that in the next five years, close to 25-30 percent of the IT workforce could potentially work from smaller towns and cities.

June 17, 2020 / 19:43 IST
Story continues below Advertisement

The Covid-19 outbreak is expected to accelerate tech growth in tier-2 and tier-3 cities with remote working becomes a norm across the sector, say experts.

Analysts and human resource professionals pointed out that in the next five years, close to 25-30 percent of the IT workforce could potentially work from smaller towns and cities.

Story continues below Advertisement

Due to the Covid-19 outbreak, hundreds of techies moved to their native places before the lockdown came into force on March 24. Companies have extended work from home facility until July and in some firms, until September.

Majority of the techies working in cities such as Bengaluru, Chennai, Hyderabad, Mumbai, Pune and Delhi- NCR hail from smaller towns and cities.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show